Park Avenue Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.7M Buy
35,602
+3,576
+11% +$3.65M 0.27% 62
2026
Q1
$29.5M Buy
32,026
+3,913
+14% +$3.97M 0.23% 74
2025
Q4
$30.2M Buy
28,113
+2,711
+11% +$2.59M 0.26% 63
2025
Q3
$19.4M Buy
25,402
+1,502
+6% +$1.12M 0.15% 106
2025
Q2
$18.6M Buy
23,900
+239
+1% +$186K 0.17% 99
2025
Q1
$19.5M Buy
23,661
+4,387
+23% +$3.65M 0.24% 63
2024
Q4
$14.9M Buy
19,274
+2,381
+14% +$1.97M 0.15% 100
2024
Q3
$15M Sell
16,893
-1,705
-9% -$1.53M 0.17% 90
2024
Q2
$16.8M Buy
18,598
+1,404
+8% +$1.12M 0.21% 75
2024
Q1
$13.4M Buy
17,194
+1,985
+13% +$1.41M 0.17% 83
2023
Q4
$8.87M Buy
15,209
+291
+2% +$170K 0.12% 111
2023
Q3
$8.01M Sell
14,918
-1,618
-10% -$834K 0.12% 108
2023
Q2
$7.75M Buy
16,536
+1,152
+7% +$483K 0.12% 112
2023
Q1
$5.28M Buy
15,384
+3,623
+31% +$1.22M 0.09% 148
2022
Q4
$4.3M Buy
11,761
+864
+8% +$306K 0.08% 169
2022
Q3
$3.52M Buy
10,897
+1,390
+15% +$440K 0.07% 170
2022
Q2
$3.08M Buy
9,507
+1,917
+25% +$575K 0.06% 194
2022
Q1
$2.17M Buy
7,590
+1,020
+16% +$263K 0.04% 261
2021
Q4
$1.81M Buy
6,570
+948
+17% +$240K 0.03% 296
2021
Q3
$1.3M Buy
5,622
+394
+8% +$97.2K 0.03% 335
2021
Q2
$1.2M Buy
5,228
+159
+3% +$31.9K 0.03% 331
2021
Q1
$947K Sell
5,069
-22
-0.4% -$4.3K 0.02% 360
2020
Q4
$860K Buy
5,091
+55
+1% +$8.21K 0.02% 326
2020
Q3
$745K Buy
5,036
+59
+1% +$9.13K 0.02% 297
2020
Q2
$817K Buy
+4,977
New +$764K 0.03% 230
2020
Q1
Sell
-4,871
Closed -$640K 466
2019
Q4
$640K Buy
4,871
+117
+2% +$13.6K 0.03% 248
2019
Q3
$532K Buy
+4,754
New +$529K 0.03% 237
2019
Q2
Sell
-3,400
Closed -$439K 376
2019
Q1
$439K Buy
+3,400
New +$413K 0.02% 241
2017
Q3
Sell
-4,028
Closed -$332K 186
2017
Q2
$332K Buy
+4,028
New +$329K 0.04% 121

Other funds holding LLY

Park Avenue Securities's LLY Position: Q2 2026 in Review

Park Avenue Securities increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $3.65M and bringing the position to 35,602 shares worth $42.7M. The position accounts for 0.27% of the portfolio, ranked #62.

Park Avenue Securities first reported a position in LLY in Q2 2017 and has held it in 29 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Park Avenue Securities held 35,602 shares of Eli Lilly worth $42.7M as of Q2 2026.
  • Park Avenue Securities bought 3,576 Eli Lilly shares in Q2 2026, an estimated $3.65M.
  • Eli Lilly made up 0.27% of Park Avenue Securities's portfolio in Q2 2026, its #62 holding.
  • Park Avenue Securities first reported a position in Eli Lilly in Q2 2017 and has held it in 29 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.